Zhuang, T.Z.; Case, K.; Olsen, T.A.; Brown, J.T.; Carthon, B.C.; Kucuk, O.; Goldman, J.; Harris, W.; Bilen, M.A.; Nazha, B.
Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials. Cancers 2022, 14, 2867.
https://doi.org/10.3390/cancers14122867
AMA Style
Zhuang TZ, Case K, Olsen TA, Brown JT, Carthon BC, Kucuk O, Goldman J, Harris W, Bilen MA, Nazha B.
Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials. Cancers. 2022; 14(12):2867.
https://doi.org/10.3390/cancers14122867
Chicago/Turabian Style
Zhuang, Tony Zibo, Katherine Case, Timothy Anders Olsen, Jacqueline T. Brown, Bradley C. Carthon, Omer Kucuk, Jamie Goldman, Wayne Harris, Mehmet Asim Bilen, and Bassel Nazha.
2022. "Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials" Cancers 14, no. 12: 2867.
https://doi.org/10.3390/cancers14122867
APA Style
Zhuang, T. Z., Case, K., Olsen, T. A., Brown, J. T., Carthon, B. C., Kucuk, O., Goldman, J., Harris, W., Bilen, M. A., & Nazha, B.
(2022). Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials. Cancers, 14(12), 2867.
https://doi.org/10.3390/cancers14122867